Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,756 | 23,419 | 22,199 | 27,029 | 27,309 |
| Receivables | 716 | 418 | 5,643 | 5,477 | 917 |
| TOTAL | $61,250 | $24,605 | $28,593 | $33,089 | $28,894 |
| Non-Current Assets | |||||
| PPE Net | 6,204 | 5,744 | 5,119 | 4,789 | 4,430 |
| Intangibles | 5,855 | 6,103 | 6,352 | 6,601 | 6,850 |
| TOTAL | $12,058 | $11,847 | $11,471 | $11,390 | $11,280 |
| Total Assets | $73,308 | $36,452 | $40,064 | $44,478 | $40,174 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 210 | N/A | 205 | 214 | 187 |
| Accounts payable and accrued liabilities | 599 | 1,141 | 477 | 617 | 1,136 |
| Accrued Expenses | 2,858 | 2,304 | 2,892 | 2,721 | 3,238 |
| Other current liabilities | N/A | 248 | N/A | N/A | N/A |
| TOTAL | $6,513 | $3,693 | $3,586 | $3,577 | $4,598 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,004 | N/A | 1,791 | 1,852 | 1,914 |
| Deferred Revenues | 2,847 | N/A | 13 | 25 | 38 |
| Other Non-Current Liabilities | 0 | 1,870 | 0 | 0 | 0 |
| TOTAL | $48,607 | $11,870 | $11,791 | $11,852 | $1,914 |
| Total Liabilities | $55,120 | $15,563 | $15,376 | $15,429 | $6,512 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 412 | 412 | 412 | 412 | 412 |
| Common Shares | 74 | 74 | 74 | 74 | 74 |
| Retained earnings | -238,844 | -235,873 | -231,893 | -227,378 | -222,644 |
| Other shareholders' equity | -228 | -1,453 | -1,628 | -1,479 | -1,600 |
| TOTAL | $18,189 | $20,889 | $24,688 | $29,050 | $33,663 |
| Total Liabilities And Equity | $73,308 | $36,452 | $40,064 | $44,478 | $40,174 |